Dianthus Therapeutics, Inc. (DNTH) Shareholders’ equity 2016–2025
Dianthus Therapeutics, Inc. (DNTH) shareholders’ equity at each fiscal year-end, per SEC filings.
$493.4MFY2025 · since FY2016: -$8.9M → $493.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $493.4M | +40.0% |
| FY2024 | $352.5M | +108.7% |
| FY2023 | $168.9M | +480.6% |
| FY2022 | -$44.4M | -157.2% |
| FY2021 | -$17.2M | — |
| FY2019 | $141.2M | -3.1% |
| FY2018 | $145.6M | +445.8% |
| FY2017 | -$42.1M | -374.6% |
| FY2016 | -$8.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice